Welcoming Jeffrey Low, MD and Tristan Hunt, MD as Bedford Bridge Partners

We are excited to announce that two new Partners are joining our team—both distinguished medical doctors and seasoned leaders in healthcare, life sciences, and technology. Please join us in welcoming Jeffrey Low and Tristan Hunt.

Jeffrey Low, MD

Jeffrey joins Bedford Bridge after nearly a decade of venture capital experience investing in early and growth-stage companies at the intersection of life sciences, healthcare, and technology. Previously at Novo Holdings and Andreessen Horowitz’s Bio Fund, he has been instrumental in investments in Exscientia, Tempus, Accolade, Freenome, Erasca and more. Jeffrey has an MD from the Yale School of Medicine, an MBA from Harvard Business School, and an AB from Harvard University. Jeffrey is based out of San Francisco and is opening our West Coast presence.

Tristan Hunt, MD

Tristan was most recently the Chief Operating Officer at Roivant Health, developing new health technology ventures. Previously, he was a Partner in the healthcare practice at BCG in New York. Among many other initiatives, Tristan co-led BCG’s Central Covid Response Team, advising public and private organizations, including 10+ US states and the US Business Roundtable. He is a senior fellow of the US Chamber of Commerce Foundation and advises the ARPA-H program as an XIR with Digitalis Commons. Tristan has an MD from Columbia University, an MBA from Columbia Business School, and a BS from the University of Notre Dame.

We couldn’t be more excited to have both Jeffrey and Tristan join the Bedford Bridge family. Thank you for your continued support and partnership as we start this next chapter for Bedford Bridge.